These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2911314)

  • 1. Antibodies to Strongyloides stercoralis in healthy Jamaican carriers of HTLV-1.
    Nera FA; Murphy EL; Gam A; Hanchard B; Figueroa JP; Blattner WA
    N Engl J Med; 1989 Jan; 320(4):252-3. PubMed ID: 2911314
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers?
    Arakaki T; Asato R; Ikeshiro T; Sakiyama K; Iwanaga M
    Trop Med Parasitol; 1992 Sep; 43(3):199-200. PubMed ID: 1470843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM; Da Fonseca Porto A
    Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies).
    Courouble G; Rouet F; Herrmann-Storck C; Nicolas M; Candolfi E; Deloumeaux J; Carme B
    West Indian Med J; 2004 Jan; 53(1):3-6. PubMed ID: 15114885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effects of concurrent HTLV-I infection in strongyloidiasis.
    Atkins NS; Lindo JF; Lee MG; Hanchard B; Robinson RD; Bundy DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):188-90. PubMed ID: 9637586
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enterococcal meningitis due to strongyloidiasis with HTLV-1 carrier].
    Sugiura A; Fujimoto M; Saida Y
    Rinsho Shinkeigaku; 2006 Oct; 46(10):715-7. PubMed ID: 17323782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
    Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
    J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.
    Hayashi J; Kishihara Y; Yoshimura E; Furusyo N; Yamaji K; Kawakami Y; Murakami H; Kashiwagi S
    Am J Trop Med Hyg; 1997 Jan; 56(1):71-5. PubMed ID: 9063365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
    Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
    Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.
    Robinson RD; Lindo JF; Neva FA; Gam AA; Vogel P; Terry SI; Cooper ES
    J Infect Dis; 1994 Mar; 169(3):692-6. PubMed ID: 8158055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant strongyloidiasis and the HTLV-I virus].
    Neisson-Vernant C; Edouard A
    Rev Prat; 1990 Oct; 40(23):2127-8. PubMed ID: 2237217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
    Jeyamani R; Joseph AJ; Chacko A
    Trop Gastroenterol; 2007; 28(4):176-7. PubMed ID: 18416349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression.
    Newton RC; Limpuangthip P; Greenberg S; Gam A; Neva FA
    Am J Med; 1992 Feb; 92(2):202-8. PubMed ID: 1543206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of Strongyloides stercoralis infection among HTLV-I infected blood donors in Barcelona, Spain: A cross-sectional study.
    Salvador F; Sulleiro E; Piron M; Sánchez-Montalvá A; Sauleda S; Molina I
    Acta Trop; 2017 Dec; 176():412-414. PubMed ID: 28939495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strongyloides stercoralis hyperinfection syndrome with acute meningoencephalitis associated to HTLV-1 and HTLV-2 virus co-infection].
    N'dri K; Kouame KE; Sahari R; Hommel D; Hulin A
    Med Mal Infect; 2008 Mar; 38(3):162-4. PubMed ID: 18191522
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis].
    Foucan L; Genevier I; Lamaury I; Strobel M
    Med Trop (Mars); 1997; 57(3):262-4. PubMed ID: 9513154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
    Freites A
    Invest Clin; 2008 Dec; 49(4):455-6. PubMed ID: 19245164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
    Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
    Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis.
    Neva FA; Filho JO; Gam AA; Thompson R; Freitas V; Melo A; Carvalho EM
    J Infect Dis; 1998 Dec; 178(6):1856-9. PubMed ID: 9815251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Porto AF; Santos SB; Muniz AL; Basilio V; Rodrigues W; Neva FA; Dutra WO; Gollob KJ; Jacobson S; Carvalho EM
    J Infect Dis; 2005 Feb; 191(4):612-8. PubMed ID: 15655786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.